(Q48172806)

English

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Elisa Marabotto

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Edoardo Savarino

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Pietro Dulbecco

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lorenzo Assandri

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Linda Bruzzone

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Fabrizio Mazza

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Anna Chiara Frigo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Valentina Fazio

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vincenzo Savarino

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

0 references

publication date

10 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

108

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1731-1742

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Primary and recurrent Crohn's disease. Experience with 1379 patients

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Recurrence rates in Crohn's disease: predicting the future and predicting the past

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Risk factors for early postoperative recurrence of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Effects of cigarette smoking on the long-term course of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Infliximab prevents Crohn's disease recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.287

21 January 2018

Identifiers

10.1038/AJG.2013.287

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24019080%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48172806&oldid=1520658864"